Align Technology, Inc.

Align Technology, Inc.(ALGN)股票分析

$154.510

-0.989 (-0.64%)收盤時

Loading chart…
最高
155.800
開盤
154.790
成交量加權均價
154.34
成交量
911.61K
市值
18.29B
最低
152.700
成交金額
140.70M
企業價值/稅息折舊攤銷前利潤(TTM)
10.69

Align Technology, Inc. is a global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad computer-aided design and computer-aided manufacturing (CAD/CAM) software for digital orthodontics and restorative dentistry. The Company provides Align Digital Platform. Its segments include Clear Aligner, and Imaging Systems and CAD/CAM Services (Systems and Services). The Clear Aligner segment consists of comprehensive products, non-comprehensive products and non-case products. Its comprehensive products include Invisalign Comprehensive and Invisalign First. The Company's non-case products include retention products, Invisalign training and adjusting tools. It offers up to four sets of custom clear aligners called Vivera retainers. The Systems and Services segment consists of its iTero intraoral scanning systems. Its services include subscription software, disposables, rentals, leases and pay per scan services.

AI 分析 of Align Technology, Inc. (ALGN)

持有

Align Technology Inc is currently a hold. The stock is trading at $154.51, which is significantly below the estimated intrinsic value of $311 per share, indicating potential undervaluation. However, the stock has a high RSI of 74.36, suggesting it may be overbought in the short term. Additionally, the forward P/E ratio is 11.67, which is attractive compared to its current P/E of 57.39, but the recent downgrades from analysts, including a target reduction to $155 from $220 by Evercore ISI, raise concerns about future growth. The main risk is the declining consumer sentiment reflected in the recent retail sales data, which fell by 0.6% month-over-month, potentially impacting Align's sales.

分析師評級(11)

上檔空間 +28.60%
買進
11 買進
0 持有
0 賣出
目前: 154.51
最低
169.00
平均
198.70
最高
220.00

Stifel

2026-10-09

目標價

$175

買進

Evercore ISI

2026-10-05

目標價

$155

In Line

UBS

2026-07-23

目標價

$189

中性

BMO Capital

2026-07-08

目標價

$209

優於大盤

Leerink

2026-06-30

目標價

$230

優於大盤

估值指標

Align Technology, Inc.(ALGN)目前預期本益比為 11.67,5 年平均預期本益比為 27.14。

預期本益比

低估
5 年均值 P/E
27.14
目前P/E
11.67
高估
40.99
低估
13.29

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
18.46
目前EV/EBITDA
10.69
高估
26.62
低估
10.30

預期股價營收比

合理
5 年均值 P/S
4.82
目前P/S
2.57
高估
7.11
低估
2.54

Alphio AI 對 ALGN 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%ALGN

$210.76

情境價格

基

基準

基準 · 50%ALGN

$171.10

情境價格

悲

悲觀

悲觀 · 25%ALGN

$159.37

情境價格

持有 ALGN 的大戶

C

Carmignac Gestion SA

+ 持有ALGN

+6.62%

3個月報酬率

T

The Investment House LLC

+ 持有ALGN

+3.43%

3個月報酬率

N

Nearwater Capital Markets, Limited

+ 持有ALGN

+3.22%

3個月報酬率

J

Jacobs Levy Equity Management Inc

+ 持有ALGN

+1.13%

3個月報酬率

C

Country Trust Bank

+ 持有ALGN

+0.38%

3個月報酬率

B

Bellevue Asset Management AG

+ 持有ALGN

-0.30%

3個月報酬率

事件時間軸

2026-10-18 (ET)

10:30:00

Align Technology Announces Patent Infringement Ruling

2026-10-05 (ET)

09:00:00

Stock Futures Point to Modestly Lower Open as Investors Take a Breather

2026-08-12 (ET)

05:30:00

Align Wins Patent Infringement Case in China, Awarded RMB 10M

2026-07-29 (ET)

20:30:00

Major US Indices Close Lower, Semiconductor Stocks Plummet

17:00:00

Sees Q3 Adjusted Gross Margin Roughly 71%

資訊

ALGN 常見問題 —— 由 Alphio AI 解答

Align Technology, Inc. is a global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad computer-aided design and computer-aided manufacturing (CAD/CAM) software for digital orthodontics and restorative dentistry. The Company provides Align Digital Platform. Its segments include Clear Aligner, and Imaging Systems and CAD/CAM Services (Systems and Services). The Clear Aligner segment consists of comprehensive products, non-comprehensive products and non-case products. Its comprehensive products include Invisalign Comprehensive and Invisalign First. The Company's non-case products include retention products, Invisalign training and adjusting tools. It offers up to four sets of custom clear aligners called Vivera retainers. The Systems and Services segment consists of its iTero intraoral scanning systems. Its services include subscription software, disposables, rentals, leases and pay per scan services. It operates in the Healthcare sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).

Align Technology Inc is currently a hold. The stock is trading at $154.51, which is significantly below the estimated intrinsic value of $311 per share, indicating potential undervaluation. However, the stock has a high RSI of 74.36, suggesting it may be overbought in the short term. Additionally, the forward P/E ratio is 11.67, which is attractive compared to its current P/E of 57.39, but the recent downgrades from analysts, including a target reduction to $155 from $220 by Evercore ISI, raise concerns about future growth. The main risk is the declining consumer sentiment reflected in the recent retail sales data, which fell by 0.6% month-over-month, potentially impacting Align's sales.

11 analysts cover ALGN: 11 rate it Buy, 0 Hold and 0 Sell. The average price target is 198.70.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易